v3.26.1
Balance Sheet
Dec. 31, 2025
USD ($)
Current Assets  
Prepaid expenses $ 4,673
Total Current Assets 4,673
Deferred offering costs 218,347
Total Assets 223,020
Current Liabilities  
Accrued expenses 5,000
Accrued offering costs 28,267
Total Current Liabilities 274,682
Total Liabilities 274,682
Commitments and Contingencies (Note 6)
Shareholder’s Deficit  
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued or outstanding
Additional paid-in capital 24,233
Accumulated deficit (76,662)
Total Shareholder’s Deficit (51,662)
Total Liabilities and Shareholder’s Deficit 223,020
Class A Ordinary Shares  
Shareholder’s Deficit  
Ordinary shares, value
Class B Ordinary Shares  
Shareholder’s Deficit  
Ordinary shares, value 767 [1],[2],[3],[4]
Related Party  
Current Liabilities  
Promissory note – related party $ 241,415
[1] Includes an aggregate of up to 1,000,000 Class B ordinary shares which will be surrendered to the Company for no consideration if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).
[2] On February 2, 2026, as a result of the partial exercise by the underwriters of the over-allotment option, 139,795 Founder Shares are no longer subject to forfeiture.
[3] On January 28, 2026, the Sponsor surrendered 1,916,666 Founder Shares to the Company for no consideration, resulting in the Sponsor holding an aggregate of 7,666,667 Founder Shares. All shares and per-share amounts have been retroactively presented.
[4] On March 11, 2026, the underwriters forfeited the remaining unexercised balance of 2,580,615 over-allotment option Units. As a result, the Sponsor surrendered 860,205 Founder Shares to the Company for no consideration.